| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Generics
1 company
Gutwerg Ori is a SVP, Generics at ANIP. Recent filings cover 0 purchases and 10 sales. Those positions are worth an estimated $5.8M at current prices.
Our model assigns Gutwerg Ori a below-average insider score of 47/100, based on 5 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -10.5%.
Gutwerg Ori's largest disclosed position is in ANIP as SVP, Generics, worth about $5.8M. The recent filings there lean toward selling, a net 38,678 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | ANIP Ani Pharmaceuticals, Inc. | SVP, Generics | Sell | 3,162 | $77.00 | $243,474.00 | -4.0% | - | - | |
| May 12, 2026 | ANIP Ani Pharmaceuticals, Inc. | SVP, Generics | Sell | 2,772 | $79.50 | $220,374.00 | -3.4% | -4.7% | - | |
| Mar 3, 2026 | ANIP Ani Pharmaceuticals, Inc. | SVP, Generics | Sell | 2,060 | $76.50 | $157,590.00 | -2.4% | +0.8% | - | |
| Aug 12, 2025 | ANIP Ani Pharmaceuticals Inc | SVP, Generics | Sell | 5,873 | $86.53 | $508,190.69 | -6.5% | +0.7% | -15.0% | |
| May 15, 2025 | ANIP Ani Pharmaceuticals Inc | SVP, Generics | Sell | 881 | $60.07 | $52,921.67 | -1.0% | +49.1% | +31.0% | |
| Mar 5, 2025 | ANIP Ani Pharmaceuticals Inc | SVP, Generics | Sale+OE | 5,384 | $60.00 | $323,049.00 | -5.4% | +3.3% | +26.7% | |
| Jun 5, 2024 | ANIP Ani Pharmaceuticals Inc | SVP, Generics | Sell | 2,985 | $67.00 | $199,995.00 | -3.7% | -5.9% | -10.6% | |
| Aug 23, 2023 | ANIP Ani Pharmaceuticals Inc | SVP, Generics | Sale+OE | 15,561 | $62.39 | $970,850.79 | -20.3% | -18.8% | -5.1% |